ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,555.74
      -0.16%
      US Tech 100
      19,116.40
      -0.98%
      Dow Jones
      40,358.09
      -0.14%
      Brent Oil
      80.775
      -0.91%
      Bitcoin
      65,899.79
      -2.52%
      Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Passage Bio Inc (PASG)

      7. Passage Bio Inc (PASG) Financials

      Passage Bio Inc

      Passage Bio Inc (PASG)

      NASDAQ
      0.831
      -0.037
      (-4.26%)
      At close: July 23 4:00PM
      Delayed by 15 minutes
      0.831
      0.00
      ( 0.00% )
      After Hours: 7:10PM
      Delayed by 15 minutes

      Passage Bio Inc Financial Summary

      The current PASG market cap is 51.22M. The company's latest EPS is USD -1.6558 and P/E is -0.51.

      Income Statement

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 00000
      Operating Income -35.88M-25.39M-23.28M-18.45M-18.05M
      Net Income -34.34M-23.86M-27.11M-16.76M-16.71M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 00000
      Operating Income -37.19M-112.9M-185.73M-138.39M-103M
      Net Income -45.63M-112.23M-185.39M-136.13M-102.06M

      Balance Sheet

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 213.24M193.7M169.26M150.55M140.53M
      Total Liabilities 42.89M43.28M42.98M39.26M35.65M
      Total Equity 170.35M150.41M126.28M111.28M104.88M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 178.61M328.01M355.08M243.55M150.55M
      Total Liabilities 4.26M23.29M36.42M42.18M39.26M
      Total Equity -56.25M304.71M318.66M201.37M111.28M

      Cash Flow

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating -22.45M-39.59M-58.75M-78.26M-18.93M
      Investing 21.22M35.19M57.64M65.24M25.25M
      Financing N/A 89k89k135k8.74M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating -39.9M-80.52M-126.88M-118.21M-78.26M
      Investing -1.69M-172.11M-45.81M25.2M65.24M
      Financing 175.6M228.75M166.66M-1.35M135k

      Stats and Ratios

      Market Cap 51.22M
      Price to Earnings Ratio -0.51
      Price to Sales Ratio 0
      Price to Cash Ratio 2.41
      Price to Book Ratio 0.47
      Dividend Yield -

      Share Statistics

      Shares Outstanding 61.64M
      Average Volume (1 week) 383.69k
      Average Volume (1 Month) 170.77k
      52 Week Change -16.90%
      52 Week High 1.79
      52 Week Low 0.5751
      Spread (Intraday) 0.04 (4.97%)

      Company Info

      Company Name Passage Bio Inc
      Address 1209 orange street
      wilmington, delaware 19801
      Website https://www.passagebio.com/home/default.aspx
      Industry biological pds,ex diagnstics (2836)